GE HealthCare And DeepHealth Team Up To Advance AI-Powered Breast Cancer Screening: Details
GE HealthCare And DeepHealth Team Up To Advance AI-Powered Breast Cancer Screening: Details
Beyond SmartMammo, the two companies plan to explore further collaboration on SmartTechnology solutions in other modalities and clinical domains, aiming to broaden access to and enhance the impact of AI-powered workflows.GE HealthCare Technologies Inc. (NASDAQ:GEHC) formed a strategic collaboration with DeepHealth, a RadNet, Inc. (NASDAQ:RDNT) to advance AI in imaging.
GE医疗技术公司（纳斯达克：GEHC）与DeepHealth达成战略合作，以推动影像人工智能。
The companies aim to develop SmartTechnology solutions that leverage AI to improve imaging interpretation, reporting, clinical collaboration, and operational efficiency.
这些公司旨在开发利用人工智能的SmartTechnology解决方案，以改善影像解释、报告、临床协作和运营效率。
Under the agreement, GE HealthCare will distribute SmartMammo and other DeepHealth solutions to imaging providers across the U.S. as part of its comprehensive imaging technology portfolio.
根据协议，GE医疗将向美国各地的影像提供商分发SmartMammo和DeepHealth的其他解决方案，作为其全面影像技术组合的一部分。
Beyond SmartMammo, the two companies plan to explore further collaboration on SmartTechnology solutions in other modalities and clinical domains, aiming to broaden access to and enhance the impact of AI-powered workflows.
除了SmartMammo，这两家公司计划在其他模式和临床领域的SmartTechnology解决方案上进一步合作，旨在扩大人工智能工作流的使用范围和影响力。
This collaboration aims to enhance breast cancer screening by integrating AI-driven clinical imaging support to improve detection and diagnosis during the critical early stages of treatment.
此次合作旨在通过整合人工智能驱动的临床影像支持，改善乳腺癌筛查，提高在治疗关键早期阶段的检测和诊断水平。
The collaboration between GE HealthCare and DeepHealth will also incorporate Smart Alerts, a DeepHealth workflow solution integrated with Senographe Pristina. This feature uses rapid AI processing to quickly identify potentially suspicious lesions, alerting imaging sites within minutes.
GE医疗和DeepHealth之间的合作还将整合Senographe Pristina的智能警报，这是一个集成了DeepHealth工作流解决方案的功能。该功能使用快速人工智能处理，可在几分钟内快速识别潜在可疑的病灶，并在警报后几分钟内提醒影像站点。
The goal is to enable same-day diagnostic exams, improve follow-up compliance, and reduce anxiety for women with potentially concerning findings.
目标是实现同日诊断检查，改善后续遵从性，并减少对潜在有疑点病变的女性的焦虑。
Roland Rott, President & Chief Executive Officer of Imaging for GE HealthCare stated, "As we look to make more personalized, patient-centered breast care a reality – AI continues to show great promise in breast cancer screening from early detection and risk prediction, to reduced callbacks and more efficient workflows for breast imaging providers."
GE医疗影像总裁兼首席执行官Roland Rott表示：“随着我们致力于实现更个性化、以患者为中心的乳腺护理的愿景- 人工智能在乳腺癌筛查方面继续展现出巨大潜力，从早期检测和风险预测，减少召回以及为乳腺影像提供商提供更高效工作流。”
Investors can gain exposure to the stock via Spinnaker ETF Series Langar Global HealthTech ETF (NYSE:LGHT) and Invesco S&P Spin-Off ETF (NYSE:CSD).
投资者可以通过Spinnaker etf系列Langar全球医疗健康科技etf（纽约证券交易所代码：LGHT）和景顺标普分拆etf（纽约证券交易所代码：CSD）获得该股的曝光。
Price Action: GEHC shares are up 0.31% at $86.21 premarket at the last check Monday.
价格走势：GEHC股价于上周一最后一次查看时盘前上涨0.31%，报86.21美元。
Image by PDPics from Pixabay
来自Pixabay的PDPics图片
- GE Vernova Vs. GE Healthcare: Betting On Power Or Medical Tech To Lead AI-Powered Future?
- GE Vernova Vs. GE Healthcare：押注电力还是医疗科技来引领人工智能驱动的未来？
